Investment firm boosts stake in Mirada Medical

2020 03 04 21 21 6197 Artificial Intelligence Ai Hand 400 20200304215813

Private equity investor Apposite Capital has made an additional investment in cancer imaging software company Mirada Medical, bringing its total investment since 2019 to $20 million.

One of Mirada's software products in development is Simplicit90Y, which enables personalized dosimetry planning for TheraSphere, a radiation-based cancer treatment that uses microscopic radioactive glass microspheres.

Mirada's software is used in over 2,000 hospitals globally, Apposite said.

Page 1 of 1250
Next Page